William Kiesman
About William Kiesman
William Kiesman Chief Technology Officer
William Kiesman serves as the Chief Technology Officer. He brings over two decades of experience in the design, development, and manufacturing of small molecule and oligonucleotide therapeutics. His wealth of knowledge and extensive background in this field make him a key leader in his organization.
William Kiesman Education and Academic Background
William Kiesman earned his B.S. and Ph.D. in chemistry from the University of Connecticut. Following his doctoral education, Kiesman pursued postdoctoral research at Duke University. His academic journey provided a solid foundation for his subsequent career in therapeutic development.
William Kiesman Previous Roles at Biogen
Before his current role, William Kiesman held the title of Vice President and Head of Oligonucleotide and Small Molecule Development at Biogen. In this capacity, he oversaw significant programs and initiatives that contributed to the advancement of the company’s therapeutic development capabilities.
William Kiesman Publications and Patents
William Kiesman is a co-author on more than 40 publications and patents. His contributions to scientific literature have been recognized in various peer-reviewed journals and books. He has also contributed to five book chapters, showcasing his expertise and commitment to the field of therapeutic sciences.